Canocapavir
Canocapavir (ZM-H1505R) is an orally bioavailable small molecule that targets the hepatitis B virus core protein. It acts as a capsid assembly modulator, inducing conformational changes in the core protein linker region to disrupt viral replication. This investigational compound is used in research exploring novel HBV therapies, with studies demonstrating antiviral activity in both cellular and animal models.
Product Specifications
CAS Number
2137847-19-7
Product Name Alternative
HBV, ZM-H1505R
Field of Research
Infectious Disease & Virology
Purity
98.40% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (8.89 mM) ; DMSO:100 mg/mL (177.81 mM)
Smiles
C (CC=1C=C2C (=CC1) NC (=O) N2) N3[C@@H] (C=4C (=NN (C4) C5=CC=C (Br) C=C5) C6=CC=C (F) C=C6) OCC3=O
Molecular Formula
C27H21BrFN5O3
Molecular Weight
562.39
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Serum Response Factor (SRF) (NM_003131) Human Over-expression Lysate
Recombinant Campylobacter Fetus hemH Protein (aa 1-314)
